Breaking
Friday, June 19, 2026

FDA News

🇪🇺 EMA Page 2

EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 13–24 of 53 articles

High impact NewsJun 4, 2026

EU Commission Advances Critical Medicines Act: Market Implications

FDA · 7 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data

FDA · cancer · 4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Owkin and AstraZeneca Enhance AI Collaboration for Drug Research

FDA · 4 min

Dr. Elena Rossi
High impact NewsJun 4, 2026

Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights

FDA · breast cancer · 5 min

Dr. Elena Rossi
Critical impact NewsJun 4, 2026

Insights from ESMO Asia: Nadia Harbeck on Oncology Advances

FDA · oncology · 4 min

Dr. Elena Rossi
High impact AnalysisJun 4, 2026

Cellectar Biosciences (CLRB) FDA Approvals, PDUFA Dates & Drug Alerts 2026

FDA · 5 min

Dr. Elena Rossi
High impact NewsJun 3, 2026

Biosimilar Approvals: U.S. vs. Europe Insights for Pharma BD

FDA · 6 min

Dr. Elena Rossi
High impact NewsJun 3, 2026

Key Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights

FDA · cancer · 5 min

Dr. Elena Rossi
High impact NewsJun 3, 2026

European Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio

FDA · rare disease · 4 min

Dr. Elena Rossi
High impact AnalysisJun 3, 2026

Tracy Beth Høeg's Departure: Implications for Pharma BD and Regulatory Teams

FDA · 6 min

Dr. Elena Rossi
High impact NewsJun 3, 2026

EMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines

FDA · 5 min

Dr. Elena Rossi
High impact NewsJun 3, 2026

X4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome

FDA · WHIM Syndrome · 5 min

Dr. Elena Rossi